PFIZER INC.

Tracked program mentions5

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

• Anti-Tamper Technology Executive Agency0605024Fmatched: “Executive|Agency”matched 2+ title words

  Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to…

• CounterIntel and Human Intel Modernization0606003Amatched: “Human|Modernization”matched 2+ title words

  Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to…

• Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words

  H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To…

• SPQ-9B Radar2026matched: “2026”PE code cited directly

  Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to…

• Teleport Program14matched: “14”PE code cited directly

  H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14

Lobbying activities5

• Copyright/Patent/TrademarkCPT

  Intellectual Property Protections and Policy S. 2658 - Medication Affordability and Patent Integrity Act

• Health IssuesHCR

  Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage

• Medicare/MedicaidMMM

  H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues

• Taxation/Internal Revenue CodeTAX

  H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14

• Trade (domestic/foreign)TRD

  H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade International Supply Chain Section 301 Investigation re: Germany Issues Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competitiveness Issues Trade Issues

Lobbyists7

• ANGELA WILES
• CATHERINE ROBINSON
• EMILY MUELLER
• FRANCISCO CARRILLO
• JENNIFER WALTON
• MATTHEW STROIA
• STEPHEN CLAEYS